Remove Cannabinoids Remove Collective Remove Conditions Remove Safety
article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52
article thumbnail

Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug

Cannabis Law Report

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. The primary endpoint of our Phase 1 clinical trial was to test and demonstrate safety and tolerability.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK: Survey Suggests That As Many As 1.4 Million Purchasing Illegal Cannabis To Treat “Chronic Conditions”

Cannabis Law Report

million adults are now using “street cannabis ” to treat the symptoms of chronic conditions , according to the largest poll of its kind. More than half (56 per cent) of those using cannabis for their conditions did so on a daily basis, with a further 23 per cent on a weekly basis. They write. New guidelines.

article thumbnail

New Study Shows Medical Cannabis Syqe Inhaler Significantly Reduced Pain in Neuropathy Patients

Veriheal

Recent research has found that aerosolized cannabis can provide long-term pain reduction, specifically in patients with neuropathy and other chronic conditions. Cannabis has the ability to alleviate pain due to the cannabinoids ability to bind to the receptors located throughout our bodies in the endocannabinoid system (ECS).

Patients 120
article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45
article thumbnail

Swinburne researchers investigate effects of medicinal cannabis on drivers after getting a tidy $358,980 from government

Cannabis Law Report

A Swinburne study into the effects on medical cannabis on driving ability has received $358,980 in funding from the federal government’s Road Safety Innovation Fund. Driver monitoring systems monitor and detect a driver’s state and collect information to make an instant assessment about their capacity to drive safely. Source: [link].

article thumbnail

Canada: Medical Cannabis & Cannabinoid Regulation 2021

Cannabis Law Report

According to the federal government, the Cannabis Act’s three stated objectives are to (i) keep cannabis out of the hands of young people, (ii) keep profits out of the pockets of criminals, and (iii) protect public health and safety by allowing adults to access legal cannabis. Use of Non-controlled Cannabinoids in Food.